Finance

Lists
Why is 2575 up 2,85%?
Dive Deeper
2575:HKG
Xuanzhu Biopharmaceutical Co Ltd
8,30 HK$
+2,85%
(+0,23) 1D
15 հոկ, 15:36:42 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2575...
Open
8,20 HK$
High
8,86 HK$
Low
8,18 HK$
Mkt. cap
4,30 մլրդ
Avg. vol.
3,25 մլն
Volume
3,01 մլն
52-wk high
96,90 HK$
52-wk low
8,00 HK$
EPS
-0,56 HK$
Shares outstanding
160,70 մլն
No. of employees
344
Open
8,20 HK$
High
8,86 HK$
Low
8,18 HK$
Mkt. cap
4,30 մլրդ
Avg. vol.
3,25 մլն
Volume
3,01 մլն
52-wk high
96,90 HK$
52-wk low
8,00 HK$
EPS
-0,56 HK$
Shares outstanding
160,70 մլն
No. of employees
344
News stories
From web sources and news partners
About Xuanzhu Biopharmaceutical Co Ltd
CEO-
Employees344
Founded2008
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
16,94 մլն
16,94 մլն
34,72 մլն
34,72 մլն
Cost of goods sold
6,67 մլն
6,67 մլն
27,05 մլն
27,05 մլն
Cost of revenue
6,67 մլն
6,67 մլն
27,05 մլն
27,05 մլն
Research and development expenses
20,24 մլն
20,24 մլն
13,75 մլն
13,75 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
46,06 մլն
46,06 մլն
32,94 մլն
32,94 մլն
Operating expense
69,54 մլն
69,54 մլն
47,10 մլն
47,10 մլն
Total operating expenses
76,21 մլն
76,21 մլն
74,16 մլն
74,16 մլն
Operating income
-59,27 մլն
-59,27 մլն
-39,44 մլն
-39,44 մլն
Other non operating income
-7,68 մլն
-7,68 մլն
1,78 մլն
1,78 մլն
EBT including unusual items
-67,30 մլն
-67,30 մլն
-37,67 մլն
-37,67 մլն
EBT excluding unusual items
-68,95 մլն
-68,95 մլն
-37,67 մլն
-37,67 մլն
Income tax expense
-
-
3,00 հզր
3,00 հզր
Effective tax rate
-
-
-0,01%
-0,01%
Other operating expenses
3,24 մլն
3,24 մլն
413,50 հզր
413,50 հզր
Net income
-67,30 մլն
-67,30 մլն
-37,67 մլն
-37,67 մլն
Net profit margin
-397,30%
-397,30%
-108,49%
-108,49%
Earnings per share
-
-
-
-
Interest and investment income
1,65 մլն
1,65 մլն
-
-
Interest expense
-47,50 հզր
-47,50 հզր
-5,50 հզր
-5,50 հզր
Net interest expenses
1,60 մլն
1,60 մլն
-5,50 հզր
-5,50 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-51,68 մլն
-51,68 մլն
-32,61 մլն
-32,61 մլն
Gain or loss from assets sale
-894,00 հզր
-894,00 հզր
-2,54 մլն
-2,54 մլն
AI content may include mistakes. Learn more
Google Apps